SC 13D/A | 2024-02-12 | Pivotal bioVenture Partners Fund I, L.P. | Inozyme Pharma, Inc. | 2,923,110 | 4.7% | EDGAR |
SC 13D/A | 2024-02-12 | Pivotal bioVenture Partners Fund I, L.P. | Rallybio Corp | 2,404,644 | 6.4% | EDGAR |
SC 13D/A | 2024-02-12 | Pivotal bioVenture Partners Fund I, L.P. | Bolt Biotherapeutics, Inc. | 3,058,419 | 8.1% | EDGAR |
SC 13G/A | 2024-02-12 | Pivotal bioVenture Partners Fund I, L.P. | Oculis Holding AG | 2,414,972 | 7.4% | EDGAR |
SC 13D/A | 2023-08-08 | Pivotal bioVenture Partners Fund I, L.P. | Inozyme Pharma, Inc. | 2,923,110 | 6.2% | EDGAR |
SC 13D/A | 2023-05-23 | Pivotal bioVenture Partners Fund I, L.P. | Inozyme Pharma, Inc. | 2,804,062 | 6.4% | EDGAR |
SC 13D/A | 2023-04-04 | Pivotal bioVenture Partners Fund I, L.P. | Inozyme Pharma, Inc. | 2,740,072 | 6.3% | EDGAR |
SC 13G | 2023-03-15 | Pivotal bioVenture Partners Fund I, L.P. | Oculis Holding AG | 3,032,296 | 9.3% | EDGAR |
SC 13G/A | 2022-08-25 | Pivotal bioVenture Partners Fund I, L.P. | Akouos, Inc. | 1,794,088 | 4.9% | EDGAR |
SC 13D | 2022-04-28 | Pivotal bioVenture Partners Fund I, L.P. | Inozyme Pharma, Inc. | 2,661,154 | 6.6% | EDGAR |
SC 13G/A | 2022-02-14 | Pivotal bioVenture Partners Fund I, L.P. | Akouos, Inc. | 1,794,088 | 5.2% | EDGAR |
SC 13G/A | 2022-02-14 | Pivotal bioVenture Partners Fund I, L.P. | Inozyme Pharma, Inc. | 1,591,154 | 6.7% | EDGAR |
SC 13D/A | 2021-08-13 | Pivotal bioVenture Partners Fund I, L.P. | Bolt Biotherapeutics, Inc. | 3,058,419 | 8.4% | EDGAR |
SC 13D | 2021-08-12 | Pivotal bioVenture Partners Fund I, L.P. | Rallybio Corp | 2,271,311 | 7.3% | EDGAR |
SC 13D | 2021-02-17 | Pivotal bioVenture Partners Fund I, L.P. | Bolt Biotherapeutics, Inc. | 1,891,467 | 5.5% | EDGAR |
SC 13G/A | 2021-02-09 | Pivotal bioVenture Partners Fund I, L.P. | Iterum Therapeutics plc | 945,085 | 1.2% | EDGAR |
SC 13G | 2021-02-09 | Pivotal bioVenture Partners Fund I, L.P. | Akouos, Inc. | 1,794,088 | 5.2% | EDGAR |
SC 13G | 2021-02-09 | Pivotal bioVenture Partners Fund I, L.P. | Inozyme Pharma, Inc. | 1,591,154 | 6.8% | EDGAR |
SC 13D | 2020-08-04 | Pivotal bioVenture Partners Fund I, L.P. | Inozyme Pharma, Inc. | 1,591,154 | 7.1% | EDGAR |
SC 13D | 2020-07-10 | Pivotal bioVenture Partners Fund I, L.P. | Akouos, Inc. | 1,794,088 | 5.5% | EDGAR |